Medicine

20 events

	Category				Providers
When will the FDA reclassify BPC-157 to Category 1? — FDA - BPC	—	$93.9K	—	Aug 20	AZRGMIKSHLMTNVGPLYPMU
Will the FDA approve retatrutide? — retatrutide (LY3437943)	—	$50.4K	—	Aug 20	AZRGMIKSHLMTNVGPLYPMU
When will Beam Therapeutics submit a BLA for Risto-cel? — Ristoglogene autogetemcel (risto-cel) - BLA	—	$24.9K	—	Aug 20	AZRGMIKSHLMTNVGPLYPMU
When will Compass Pathways submit a NDA for COMP360 psilocybin?	—	$24.5K	—	Aug 20	AZRGMIKSHLMTNVGPLYPMU
When will the FDA approve Compass Pathways' COMP360 Psilocybin? — COMP360 Psilocybin for Treatment-Resistant Depression	—	$23.2K	—	Aug 20	AZRGMIKSHLMTNVGPLYPMU
Will New Jersey’s annual-average employment in Pharmaceutical and Medicine Manufacturing for 2026 be above 30,300 jobs?	Markets	$12.8K	—	Aug 22	AZRGMIKSHLMTNVGPLYPMU
Will the FDA approve MDMA for PTSD?	—	$11.1K	—	Aug 20	AZRGMIKSHLMTNVGPLYPMU
Will the FDA approve a cure for Type 1 Diabetes before 2033?	—	$10.4K	—	Jul 6	AZRGMIKSHLMTNVGPLYPMU
Will the FDA approve cytisinicline for smoking cessation?	—	$10.1K	—	Sep 30	AZRGMIKSHLMTNVGPLYPMU
Will North Carolina’s employment in Pharmaceutical and Medicine Manufacturing for December 2026 be above 26,500 jobs?	Markets	$9.7K	—	Sep 2	AZRGMIKSHLMTNVGPLYPMU
What will the FDA's decision be on Ivonescimab by Summit Therapeutics in 2026?	Markets	$8.9K	—	Jul 6	AZRGMIKSHLMTNVGPLYPMU
Will the FDA approve CagriSema?	—	$7.4K	—	Aug 20	AZRGMIKSHLMTNVGPLYPMU
When will the FDA approve Intellia Therapeutics' lonvo-z? — Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema	—	$6.5K	—	Aug 20	AZRGMIKSHLMTNVGPLYPMU
What will the FDA's decision be on Bepirovirsen by GlaxoSmithKline in 2026?	Markets	$4.2K	—	Jul 6	AZRGMIKSHLMTNVGPLYPMU
What will the FDA's decision be on Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences in 2026?	Markets	$3.7K	—	Jul 6	AZRGMIKSHLMTNVGPLYPMU
Will the FDA approve intismeran autogene (V940/mRNA-4157)? — intismeran autogene (V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment of completely resected stage IIB-IV melanoma	—	$2.0K	—	Aug 21	AZRGMIKSHLMTNVGPLYPMU
Will the FDA approve VERVE-102?	—	$1.7K	—	Aug 20	AZRGMIKSHLMTNVGPLYPMU
What will the FDA's decision be on Saroglitazar by Zydus Therapeutics in 2026?	Markets	$1.2K	—	Jul 12	AZRGMIKSHLMTNVGPLYPMU
What will the FDA's decision be on Venglustat by Sanofi in 2026?	Markets	$969	—	Jul 6	AZRGMIKSHLMTNVGPLYPMU
What will the FDA's decision be on BBP-418 by Ml Bio Solutions Inc. in 2026?	Markets	$837	—	Jul 6	AZRGMIKSHLMTNVGPLYPMU

Showing 1–20 of 20

[ Medicine ]

Medicine